Naltrexone Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

23 Suppliers, 9 USDMF, 7 CEP/COS, 2 EU WC, 6 KDMF, 35 NDC API, 17 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

47 Dossiers, 23 FDA Orange Book, 12 Europe, 4 Canada, 2 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 35 Kerry, 18 Corel Pharma Chem, 17 BASF, 12 Seppic, 11 Sigachi Industries, 11 Microlex e.U, 10 Roquette, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 8 DKSH, 8 Gangwal Healthcare, 8 Actylis, 6 DFE Pharma, 6 Lonza Capsugel, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Kima Chemical, 4 Nanjing Well Pharmaceutical, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 ACG Worldwide, 3 The Dow Chemical Company, 3 Prachin Chemical, 3 Vasa Pharmachem, 2 Seqens, 2 Jai Radhe Sales, 2 Evonik, 2 Qualicaps, 2 Nomisma Healthcare, 1 Valens Pharmachem, 1 SPI Pharma, 1 Aeon Procare, 1 Vertellus, 1 Finar, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Alcedo Pharmachem, 1 Clariant, 1 Ingredion Pharma Solutions, 1 Nanjing Bold Chemical, 1 Pfanstiehl, 1 Pharmatrans-Sanaq

EXCIPIENTS BY APPLICATIONS

61 Coating Systems & Additives, 52 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 23 Thickeners and Stabilizers, 21 Direct Compression, 19 Solubilizers, 18 Granulation, 16 Disintegrants & Superdisintegrants, 14 Lubricants & Glidants, 13 Parenteral, 12 Topical, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 11 Taste Masking, 9 Empty Capsules, 7 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Finished Drug Prices

MARKET PLACE

15 APIs, 3 DOSSIERS // FDF

PATENTS

86 US Patents

86 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 7 Others

DIGITAL CONTENT

47 News

47 News

Manufacturers & Suppliers of Naltrexone Hydrochloride Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Naltrexone Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

23 Suppliers

9 USDMF

7 CEP/COS

2 EU WC

6 KDMF

35 NDC API

17 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

47 Dossiers

23 FDA Orange Book

12 Europe

4 Canada

2 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

35 Kerry

18 Corel Pharma Chem

17 BASF

12 Seppic

11 Sigachi Industries

11 Microlex e.U

10 Roquette

10 Gangwal Chemicals

9 Ideal Cures Pvt Ltd

8 DKSH

8 Gangwal Healthcare

8 Actylis

6 DFE Pharma

6 Lonza Capsugel

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Kima Chemical

4 Nanjing Well Pharmaceutical

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 ACG Worldwide

3 The Dow Chemical Company

3 Prachin Chemical

3 Vasa Pharmachem

2 Seqens

2 Jai Radhe Sales

2 Evonik

2 Qualicaps

2 Nomisma Healthcare

1 Valens Pharmachem

1 SPI Pharma

1 Aeon Procare

1 Vertellus

1 Finar

1 Qianhao Chemical (Hebei) Co., Ltd

1 Alcedo Pharmachem

1 Clariant

1 Ingredion Pharma Solutions

1 Nanjing Bold Chemical

1 Pfanstiehl

1 Pharmatrans-Sanaq

EXCIPIENTS BY APPLICATIONS

61 Coating Systems & Additives

52 Fillers, Diluents & Binders

42 Controlled & Modified Release

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons